February, 2024
February 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
26272829  
Hagop Kantarjian: A new standard of care in newly diagnosed older FLT3-mutated AML
Feb 8, 2024, 05:16

Hagop Kantarjian: A new standard of care in newly diagnosed older FLT3-mutated AML

Hagop Kantarjian, Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center, shared on X:

Aza + ven + gilteritinib highly effective in newly diagnosed older FLT3-mutated AML: CR/CRi 96% and 18-month OS 72%. A new standard of care in this population.”

Visit the article website.
Source: Hagop Kantarjian/X